Evidence map›Paper›PMID 30697418›Full record

ReviewClinical and translational allergy2019

The roadmap for the Allergology specialty and allergy care in Europe and adjacent countries. An EAACI position paper.

N Fyhrquist, T Werfel, M B Bilò, N Mülleneisen, R Gerth van Wijk

Open access · goldAbstract readReview
In one paragraph

Review in Clinical and translational allergy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Allergy education and training for physicians.The World Allergy Organization journal · 2021
    Review
  13. Article
  14. Review
  15. Googling Allergy in Ireland: Content Analysis.Journal of medical Internet research · 2020
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 4 countries.

N Fyhrquist1Unit of Systems Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
T Werfel2Department of Dermatology and Allergy, Hannover Medical University, Hannover, Germany.
M B Bilò3Allergy Unit, Department of Internal Medicine, University Hospital Ospedali Riuniti, Ancona, Italy.
N MülleneisenAsthma and Allergy Center, Leverkusen, Germany.
R Gerth van Wijk5Section of Allergology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.ORCID 0000-0002-9608-8742
Erasmus MC · NLKarolinska Institutet · SEKlinikum Leverkusen · DEMedizinische Hochschule Hannover · DEOspedali Riuniti di Ancona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The high prevalence of allergic diseases warrants for sufficient health care provisions available to patients with allergic diseases. Allergy care should be delivered by well-trained specialists. However, the current status of allergy care is not well documented. For this reason a survey among European and a few non-European countries was launched by the National Allergy Society Committee from the European Academy of Allergy and Clinical Immunology and the Union Européenne des Médecins Spécialistes section and board of Allergology. The survey shows that in the vast majority of countries allergy care services are available. However, a substantial heterogeneity is reported regarding recognition of the full specialty, the number of practicing specialists or subspecialists, and training aspects. Growth but also decline of specialty and subspecialties is reported. In addition, the survey gives insight in strengths, weaknesses, opportunities and threats in this field. It appears that the recognition of the full specialty determines strength as well as weakness. Aging of specialists combined with a decline in the number of trainees form a major threat. Opportunities are seen in creating awareness for allergy, focus on attracting young physicians. The conclusion is that harmonization of allergy services across Europe is needed. Investment in young doctors, creating new opportunities and lobbying for the full specialty is required.

Indexed as

AllergologyAllergyAllergy careSpecialtySubspecialtyTraining

Identifiers

PMID30697418
PMCPMC6345018
OpenAlexW2913493525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.